However, this list is far from complete and the reader is referred to the following accounts for further details and source references: Guckian & Perry (1966) , Holdstock et al. (1979) , MacSween (1980) . The association between hepatic granulomas and some of these conditions has been established only on retrospective review and may well be coincidental. For instance, the finding of hepatic granulomas in patients with infectious mononucleosis, hepatic cirrhosis, intra-abdominal neoplasms and in association with ingestion of many different drugs may well conceal a different underlying pathological process. Many of the causes are rare and are strongly influenced by the geographical location of the patient.
Most of the reviews of patients with hepatic granulomas have come from the USA, the largest series being reported by Klatskin (1977) who found granulomas in 565 (10%) out of 5500 liver biopsies. He described 319 patients (56%) as having generalized granulomatous disease, 74 (31%) as having primary hepatic disease, 35 (6%) as having miscelIaneous conditions, and 37 (7%) in whom no definite diagnosis could be reached. Sarcoidosis and tuberculosis alone accounted for 287 (87%) of the cases with generalized granulomatous disease; this is in agreement with other reports. Fungal disease is not mentioned by Klatskin, whereas histoplasmosis was found in 12% of cases in Ohio (Mir-Madjlessi et al. 1973) . In every review there is an idiopathic group which accounts for between 7% and 36% of cases and poses a continuing diagnostic problem. This paper wiII concentrate on the problem as seen in the United Kingdom, based on two recent series in London and Glasgow (Neville et al. 1975 , Cunningham et al. 1982 .
Liver biopsy findings
The pathologist can sometimes provide further diagnostic information from the liver biopsy in a few specific conditions. Extensive caseous necrosis with acid and alcohol-fast bacilIi are diagnostic of tuberculosis, although only a small proportion of cases show either of these features. The ova in schistosomiasis and the Toxocara larvae may both be recognized within granulomas. Granulomas surrounding and involving damaged bile ducts suggest primary biliary cirrhosis or large-duct obstruction when there is usually accompanying acute 'Accepted 16 November 1982 0141-0768(83/050393-05/$01.00/0 cholangitis. Q fever may produce a typical appearance in the granuloma, with an eosinophilic fibrinoid ring and a clear central space probably enclosing a fat vacuole (Pellegrin et aJ. 1980) . Rarely, serial sectioning may reveal foreign-body and doublyrefractile material or that the granuloma involves the walls of arterioles. Plentiful eosinophils might suggest the possibility of a drug reaction, but parasites and Hodgkin's disease must also be considered. Thus, while histological clues serve to narrow the field in a few cases, in the vast majority no further information beyond the presence of granulomas can be gleaned from the biopsy.
Clinical features
The clinician is usually faced with an ill patient and an extensive list of differential diagnoses. Unless the liver biopsy has been carried out specifically to look for granuloma, as in sarcoidosis or miliary tuberculosis, then the clinical reasons for undertaking a biopsy will be very varied and the finding of granulomas usually a surprise to the clinician. No uniform clinical pattern of illness accompanies hepatic granulomas and the indications for liver biopsy will include enlargement of liver or spleen, abnormal liver function tests, jaundice or investigation of pyrexia of unknown origin.
The clinical history may be helpful. Marked weight loss would suggest tuberculosis, neoplasm or inflammatory bowel disease. Headaches and myalgia might indicate a form of arteritis. Any recent trips abroad should be documented, especially with respect to schistosomiasis in the Middle East and North Africa and airborne fungal infections in the USA. An occupational history may point to the risk of brucellosis in farmers and vets, and chronic beryllium poisoning in the electrical and atomic energy industries. A full recent drug history is required. , Clinical examination is rarely of significant further help. Pyrexia, lymphadenopathy and skin lesions may be noted. 
Investigation
Assuming that no cause for hepatic granulomas is immediately apparent from the clinical history or examination, then a reasonable series of planned investigations is suggested (see Table 2 ). The baseline investigations should be considered in all patients and the second-line tests used selectively only if the diagnosis is still in doubt. This investigation protocol is by no means all-inclusive but should reveal the most important underlying conditions.
The infectious diseases are always important conditions not to miss as cures are so easily obtained. Tissue biopsies of liver, lung, lymph nodes or marrow may be helpful in allowing an assessment of the extent of granulomatous disease and by providing specimens for culture for Mycobacteria, Brucella, Pasteurella and fungi. Occasionally guinea-pig inoculation with biopsy material may assist in the bacteriological recognition of mycobacterial infections.
Primary biliary cirrhosis is usually recognized on the initial liver biopsy but very occasionally granuloma may be the only early histological feature, in which case the finding of a positive mitochondrial antibody is useful in pointing to the need for an examination of further liver sections. Gallstones and biliary obstruction may lead to granuloma formation around bile ducts, and ultrasound examination or some form of biliary radiography may be appropriate. Although most granulomas found in patients with underlying liver disease prove to be nonspecific, the possibility of coexistent granulomatous disease must always be ruled out.
Management
In most patients treatment is usually straightforward once the diagnosis has been made. However, two subgroups of patients with hepatic granulomas may present particular problems and therefore warrant further discussion. These are patients suffering from granulomas associated with drug reactions and those in an idiopathic group.
Drug reactions
Drug hypersensitivity reactions are always listed among the causes of hepatic granulomas, but they are probably rather rare and no cases were recognized in either of the two recent British series (Neville et al. 1975 , Cunningham et al. 1982 . Klatskin (1977) reports 13 (2.3%) of his large series as being toxic or drug-induced but does not give further details.
The main problem is establishing that the drug is the cause of granuloma formation when so many diverse alternative diagnoses are possible. The following criteria have been used to judge whether the evidence for a drug aetiology was adequate: a clear temporal relationship between use of the drug and onset of the adverse reaction; clinical, biochemical and histological recovery after withdrawal of the drug and a reasonable attempt to exclude other causes of transient hepatic granulomas. Drug rechallenge has almost never been carried out. Only a handful of predominantly single case studies are available and of these phenylbutazone (Ishak et al. 1977) , sulphonamide (Espiritu et al. 1967) , chlorpropamide (Rigberg et al. 1976) , allopurinol (Medline et al. 1978) , hydralazine (Jori & Peschle 1973) , halothane (Dordal et al. 1970 ) and quinidine (Geltner et al. 1976 ) fulfil the criteria.
However, McMaster & Hennigar (1981) have suggested that many cases of drug-induced hepatic granulomas are probably being missed, for they concluded that 28 cases in their own retrospective survey of 95 patients were probably (14 cases) or possibly (14 cases) related to drugs. A wide range of different drugs had been given to these 28 patients and only 7 had a repeat liver biopsy after drug withdrawal which in 5 patients showed histological recovery. These 5 patients were taking sulphonamide (3), hydralazine (I) and diazepam (I). Common features of their drug-related cases were fever, hepatomegaly and an eosinophilic infiltrate in the liver biopsy. However, tissue eosinophilia may also be found in conditions such as histoplasmosis, schistosomiasis, Toxocara infection and Hodgkin's disease.
It would seem reasonable to be alert to the possibility of a drug reaction in all patients, to withdraw any possible offending agents but at the same time continue investigations into alternative causes.
Idiopathic hepatic granulomas
No firm diagnosis is made in 7-36% of patients with hepatic granulomas who become a considerable management problem. They present with rather nonspecific features of anorexia, weight loss, abdominal pain, pyrexia and enlargement of liver or spleen (Cunningham et al. 1982) . Pyrexia of unknown origin (Simon & Wolff 1973 , Israel & Goldstein 1973 and abdominal pain (Shee & Creamer 1980) have been emphasized as frequent clinical associations. Many of the patients had remained ill for several years (Simon & Wolff 1973 , Cunningham et al. 1982 .
If these patients are kept under regular medical review then a clear diagnosis can be made in a substantial number of cases (Guckian & Perry 1968 , Cunningham et al. 1982 ). In the latter study 17 patients were followed up and single examples of the following conditions were subsequently diagnosed: tuberculosis, sarcoidosis, primary biliary cirrhosis, ulcerative colitis, carcinoma of rectum, hepatoma, alpha-l-antitrypsin deficiency and pulmonary fibrosis, Kveim-negative pulmonary fibrosis, gallstones, rheumatic heart disease and one death from mesenteric artery thrombosis. Therefore only 6 patients remained truly idiopathic: 3 recovered spontaneously and 3 have persistent granulomas associated with continuing illness.
Patients with persisting idiopathic hepatic granulomas are more likely to be suffering from unusual manifestations of a common disorder than from an obscure disease. Tuberculosis does not often produce caseation in the liver and alcohol and acid-fast bacilli are demonstrable in only about 10% of proven cases (Klatskin 1977) . Repeat liver biopsy for culture and a trial of antituberculous therapy are always worth considering. Good therapeutic responses to antituberculous therapy have been obtained despite an inability to isolate tubercle bacilli (Fitzgerald et al. 1971 , Simon & Wolff 1973 . It is possible that these responses could have been due, for example, to the suppressive effect of streptomycin on brucellosis, but more likely they represent true responses to infection with atypical mycobacterial strains (Patel 1981) . Israel & Goldstein (1973) suggest that many of these patients have sarcoidosis with a negative Kveim test but granulomas demonstrable in other extra-abdominal organs. Corticosteroid therapy was effective in controlling symptoms in their patients but the granulomas did not disappear. Simon & Wolff (1973) adopted a more cautious approach of giving steroids only to patients who had failed to respond to antituberculous therapy, and demonstrated clearing of granulomas in 6 patients.
The management of patients with hepatic granulomas will often considerably tax the clinician's diagnostic abilities. Most of the disorders leading to granuloma formation in the liver are serious and readily treatable. A diagnosis of idiopathic hepatic granulomas should not be made unless regular follow up and review of the diagnosis is planned. Mycobacterial infections should always be considered and a trial of antituberculous therapy may well be justified. The role of corticosteroid therapy is not yet clearly defined.
